DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence Revolutionizing the Pharmaceutical Industry" report has been added to ResearchAndMarkets.com's offering.
The impressive advances in life sciences research and development (R&D) befallen in the past two/three years are playing a leading role in the transformation of the healthcare industry.
A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approaches are extensively enlightening drug discovery and the development landscape for the effective treatment of diseases. AI is pursued to provide the best suited approach to leverage scientific literature, patients' omics-data and overall clinical data to drive smart decisions.
Key Topics Covered:
1. Executive Summary
2. Technology Snapshot And Trend
3. Technology Status Review And Assessment
4. Artificial Intelligence Business Landscape
5. Artificial Intelligence Benchmarking Model
6. Artificial Intelligence Innovation Scorecard
7. Funding And Investment
8. Technology Trends And Roadmapping
9. Key Industry Influencers
10. Appendix
Companies Mentioned
AcuraStem BenevolentAI Berg Evid Science FDNA Inoplexus Kyndi ReviveMed Standigm Structura BioFor more information about this report visit https://www.researchandmarkets.com/research/srhxmj/artificial?w=4
